Objectives To evaluate the association between patient age, other clinical factors and mortality following radical cystectomy for treatment of bladder cancer.
Introduction
Bladder cancer is one of the most common genitourinary tract malignancies and is primarily a disease of the elderly. The median age at diagnosis is 69 years for men and 71 years for women. 1 Radical cystectomy with bilateral pelvic lymph node dissection remains the standard treatment for patients with muscle-invasive bladder cancer (MIBC) and provides the best survival outcomes. 2 However, such surgery is associated with major morbidity and mortality. The early postoperative complication rate ranges from 25 to 57% 3, 4 and early mortality rate is about 3%, 5 and is even higher in elderly patients. 6 Mean life expectancy is increasing in Hong Kong and many other countries. According to a survey by the United Nations, the life expectancies at birth for males and females in Hong Kong are 79 and 85 years, respectively, and are the second highest in the world after Japan. 7 A rising trend in the incidence of bladder cancer and an increase in the number of elderly patients living with bladder cancer is therefore to be expected. Treatment of MIBC in elderly patients remains a challenge. Moreover, the actual benefits of radical cystectomy in elderly patients, in terms of oncological control and perioperative mortality, remain questionable. Instruments for risk stratification and outcome prediction have been developed. 8 In the current study, we retrospectively reviewed clinical outcomes in patients with bladder cancer treated by radical cystectomies, with particular attention to any differences in postoperative mortality rates for younger and older patients.
Methods
We retrospectively reviewed the clinical and pathological data of patients who were treated by radical cystectomy for bladder cancer between May 2003 and March 2011 in a single urology unit. Preoperative evaluation included transurethral resection (TUR) of the bladder tumour and computed tomography. All grades and stages were reported according to the World Health Organization/International Society of Urologic Pathology (1998) classification and the 2002 American Joint Committee on Cancer guidelines, respectively. Open, laparoscopic, or robot-assisted cystectomies were performed according to surgeons' preferences. Patient demographic data, pre-morbid status, tumour parameters, perioperative outcomes, and survival data were retrieved from computerised clinical records. The Charlson Comorbidity Index (CCI) was used to classify co-morbid conditions before radical cystectomy. Patients were further stratified according to age into groups of ≤75 years and >75 years. The 30-day, 5-year cancer-specific, other-cause, and overall mortalities were calculated and analysed.
Continuous variables were expressed as means (± standard deviations [SDs]), and compared using Student's t tests. The χ 2 test was used to compare categorical variables. The 30-day mortality, cancerspecific, other-cause, and overall mortality rates at 5 years in different age-groups were compared using the Kaplan-Meier method with the log-rank statistic and the competing risk analysis 9 using R software.
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A Cox regression model was used to identify the predictors of mortality. Subjects' survival data were checked, and no loss to follow-up was noted; every censored case was surviving on 30 September 2011. 
Results

Demographics
A total of 117 radical cystectomies were performed between 2003 and 2011, of which 99 (85%) were in males. The mean age of the overall sample was 68 (range, 43-89) years. There was no lost of followup during the study period and the mean (± SD) Age, Charlson Comorbidity Index, tumour stage, and preoperative serum albumin level
Of the 117 patients, 83 (71%) were aged ≤75 years and 34 (29%) were aged >75 years. The CCI for 98% of the overall sample was 0 or 1-2 (66% and 32%, respectively). In all, 62 (53%) of the patients had preoperative serum albumin levels of ≤39 g/L and 55 (47%) had higher levels. Overall, 29%, 27%, 27% and 15% of the patients had T1, T2, T3 and T4 bladder cancers, respectively. There were 18 patients (15%) with lymph node metastasis.
Univariate analysis identified age at surgery, tumour stage, preoperative serum albumin level, and pathological grade as independent predictors of overall mortality at 5 years post-radical cystectomy. The multivariate analysis indicated that younger age at surgery, lower tumour stage, and a higher preoperative serum albumin level were significantly associated with improved overall survival ( Table 2) .
Cancer-specific, other-cause, and overall mortalities according to age
The data were further analysed according to age at operation. The mean follow-up time was 34 months for those aged ≤75 years and 24 months for those aged >75 years. More patients in the elderly group received an ileal conduit as urinary diversion than in the younger age-group (100% and 75%, respectively; P=0.001). Elderly patients also had lower preoperative serum albumin levels and higher CCIs. There were no statistically significant differences between the two age-groups in terms of the follow-up duration, preoperative characteristics, tumour stage, surgical approach, and length of hospital stay ( Table 1 ).
The 30-day mortality rates were 1% in patients ≤75 years and 10% in patients >75 years; the ensuing difference was statistically different (log-rank P=0.041). There was no significant difference in the 5-year cancer-specific mortality estimates between the younger and elderly groups (33 vs 33%, P=0.956; Fig 1a) . However, there were significant differences in the respective 5-year other-cause (Fig 1b) and overall (Fig 2) mortality rates, being 13% and 46% for the younger group and 47% and 80% in the older group. 
Cancer-specific, other-cause, and overall mortalities according to serum albumin level
The preoperative serum albumin level was a strong predictor of postoperative mortality (Fig 3) . The 5-year cancer-specific, other-cause, and overall mortality rates were significantly higher in patients with preoperative serum albumin levels of ≤39 g/L, being 42%, 33% and 75%, respectively, whilst in those with higher levels the respective mortality rates were 24%, 12% and 36%.
Discussion
Bladder cancer is a disease of the elderly. 1 Almost a quarter of patients had MIBC at the time of presentation. The standard treatment for MIBC is radical cystectomy with bilateral pelvic lymph node dissection. The benefit of major surgery in advanced age remains questionable and surgeons tend to avoid cystectomy in elderly patients. 11 Reports have shown that cystectomy can be performed safely in selected elderly patients without significantly increasing complication rates or mortality.
12-14 Some series reported no significant difference between the cancer-specific and overall survival rates following cystectomy for patients younger and older than 70 years. 15 Hong Kong has one of the highest life expectancies in the world. According to the United Nations World Population Prospects, life expectancy at birth is 80 years for males and 86 years for females in Hong Kong. 7 Treatment of MIBC in elderly patients remains a challenge, especially in an ageing population. In this study, we evaluated the predictors of survival in patients undergoing radical cystectomy.
Several studies have reported that after radical cystectomy, the median length of hospital stay for patients >75 years is longer than that for younger patients. 16, 17 According to an analysis based on the Surveillance, Epidemiology and End Results registry database, when compared with younger patients, 90-day mortality after radical cystectomy was 2.8-fold higher in those aged >70 years and 5-fold higher in octogenarians. 6 In the elderly moreover, long-term outcome and survival rates are also compromised. Lughezzani et al 18 reported that both the disease stage and patient age were the predictors of survival. Age is also one of the main factors influencing other- cause mortality, 19 which implies that after stratifying according to stage, elderly patients are more likely to die from causes unrelated to their radical cystectomy, even if their bladder cancer is cured. Our present findings are in line with such reports in the literature. Although the cancer-specific mortality rates were similar in both patient groups, other-cause mortality played the most important role in the higher overall mortality in elderly patients. This finding has important implications for the premise that radical cystectomy is the treatment of choice for MIBC in elderly patients. Thus, some surgeons may prefer TUR with radiotherapy to treat this condition in elderly patients. Chamie et al 19 reported a marginal survival benefit of 3 months for cystectomy over bladdersparing strategies in patients aged ≥80 years. However, Faba et al 20 reported that patients with MIBC treated with TUR had a lower perioperative complication rate but higher cancer-specific mortality.
Poor nutrition is known to have a detrimental effect on postoperative outcomes. 21, 22 A recent study confirmed that nutritional deficiency (preoperative serum albumin level <35 g/L, body mass index <18.5 kg/m 2 , weight loss ≥5%) is a strong predictor of 90-day mortality and poor overall survival. 23 We found that a preoperative serum albumin level of ≤39 g/L was associated with worse cancer-specific, other-cause, and overall survival rates.
Limitations of our study included potential selection bias and small sample size. Cystectomy candidates with multiple co-morbidities (such as the elderly) are more likely to be offered alternatives other than major surgery. Increased co-morbidity is reported to confer increased overall mortality and cancer-specific mortality after radical cystectomy. 24 The American Society of Anesthesiologists score or Eastern Cooperative Oncology Group performance status score are commonly used as subjective measures of a patient's pre-morbid status. In our study, we used the CCI as it is a simple and valid method of estimating the risk of death. Morgan et al 25 developed a nomogram based on different preoperative clinical factors to predict survival after radical cystectomy in elderly patients. Age, CCI, tumour stage, and the preoperative serum albumin level were used to calculate the probability of 90-day survival. In the current study, CCI was not a predictor of survival according to the Cox regression model. In our cohort, however, only 2% of the patients had a CCI of ≥3 in our cohort. This is much lower than the data published by Morgan et al, 25 in which 17% of patients had a CCI of >3. Our mean follow-up duration was 31 ± 29 months. A longer follow-up is necessary to address long-term survival. Due to poor documentation in the clinical record, the status and duration of cigarette smoking were not included in our multivariate analysis. In the literature, the correlation between smoking status and outcome after radical cystectomy is controversial. 26, 27 Better documentation of smoking habits is needed to assist future investigators to evaluate this issue.
Conclusion
Age at cystectomy, cancer staging, and preoperative serum albumin level are the predictors of survival after radical cystectomy. Greater other-cause mortality in elderly cystectomy patients was observed in our high longevity population. This information should be provided and discussed with patients and their relatives, before considering radical cystectomy for the treatment of MIBC.
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